SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Haleon Recalls Eight Lots of Robitussin Honey CF Max Day and Nighttime Due to Microbial Contamination
The company states that no adverse events have been reported due to the contamination as of yet.
Weeding Out Data Inconsistencies in CDL: Q&A With Roxy McCloskey, Thought Leader at SCIEX
McCloskey discusses the steps that drug developers can take to ensure better CLD outcomes in 2024.
Pusan National University Announces Potential Breakthrough for Muscle Regeneration Using Nanotech
According to the university, new nanotech scaffolding can be used to support tissue growth.
Building Awareness of Anti-Obesity Drugs: 2024 Trends
Experts weigh in on recent trends regarding weight loss medication and how they expect those trends to evolve in the coming year.
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024
The data was collected during the LEAP clinical program, developed in partnership with Merck.
Regulatory Concerns for AI: 2024 Trends
As the technology becomes more ingrained within the Pharma industry’s processes, experts believe that regulation covering the use of AI is coming.
Precision Medicine’s Breakout Year: 2024 Trends
Investors may be attracted to precision medicine and gene therapy in the coming year due to a variety of reasons, including the treatments’ abilities to produce exact responses.
FDA Clears AnX Robotica’s NaviCam SB for Expanded Indications
The device can produce AI-assisted readings.
Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023
The company also announced that it has submitted its new glucose monitoring system to the FDA for approval.
Mucinex Survey Reveals Americans Only Feel Healthy For Half of Every Month
The survey is part of the brand’s new marketing campaign.
S&P Global Releases Healthcare Industry Outlook for 2024
While the industry as a whole still faces challenges, there are positive trends appearing for pharmaceutical and medical device companies.
Evaluate Acquires J+D Forecasting
Both companies are now under the Norstella umbrella.
HBA Announces 2024 Woman of the Year
The Healthcare Businesswomen’s Association will honor the recipient at an event later this year in New York City.
How Quantum Computing Trends Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag
Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.
The Top 5 Q&As of 2023
Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.
The Top 5 DE&I Stories in 2023
As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023.
Top Marketing Stories of 2023
Pharma marketing teams had to deal with big changes in 2023.
Top 5 AI Stories of 2023
As this exciting technology exploded in 2023, Pharm Exec was there to cover it all.
The Cover Stories of 2023
These stories graced the cover of Pharmaceutical Executive this year
The Importance of Data in 2024: Q&A With Christoph Bug, Vice President of Global Medical at Veeva
Data will continue to grow in importance in 2024.
Finding that Spark
Lisa Conte, founder, president, and CEO of Jaguar Health, discusses how a climb up Mount Kilimanjaro would vault her to her true career calling—and spark a decades-long quest to accelerate breakthroughs in plant-based pharmaceuticals and supportive care.
Clearing Away the Clutter: Implementing Value-Based Contracting in Pharma
Experts gauge whether the needle is finally moving on the effective structuring of outcomes centered payment agreements—from operational, technology, and acceptance standpoints.
It’s Always Important to Remember: Leaders Make Mistakes
Continuous learning a vital skill for aspiring and established leaders alike.
Market Trends To Watch in 2024: Q&A With Seth Farbman, Chairman and Co-Founder of VStock Transfer
Farbman discusses the struggles that pharma companies are facing when trying to raise funds and how this is impacting IPOs.
Mapping the Reproductive Patient Journey: Q&A With David Powley, VP of Reproductive Medicine and Maternal Health and Operations at Ferring Pharmaceuticals
Powley discusses his team’s recent patient journey mapping exercise and the impact it has had on RMMH.
Reacting to Trends: Q&A With Leslie Orne, CEO of Trinity Life Sciences
Orne discusses the forces impacting the life sciences market and how companies are reacting.
Building a Better Toolbox For Patient Enrollment: Q&A With Kimberlee Heidmann, Co-Founder of Scout Clinical
Heidmann discusses the difficulties of enrolling patients in clinical trials and the ways these issues can be dealt with.
Piloting New Drug Development: Q&A With Dr. Bruce Leuchter, Ceo of Neurvati
Leuchter discusses FDA’s new pilot program.
Getting Proactive About Signal Detection: Q&A With Elizabeth Smalley, Director of Product Management, Data, and Analytics at ArisGlobal
Smalley discusses her work with proactive signal detection.
New Ways to Battle Cancer: Q&A With William Ho, CEO of IN8bio
Ho discusses how gamma-delta T cells can improve cancer treatments.